Aromatase Inhibitors in Men

Estradiol management, AI use, and controversies in male hormone optimization.

1 published deep analysis

Ask about this topic Back to Men's Hormone Health

Published deep analyses

Evidence in this subtopic

Do aromatase inhibitors in men increase

Do aromatase inhibitors in men increase bone loss risk?

Aromatase inhibitors lower estradiol and can reduce bone mineral density in men. Routine use to suppress estradiol during testosterone therapy is not supported by outcome evidence and may carry skeletal risk.

Moderate confidence14 curated studiesPublished analysis

Open deep analysis →

Explore adjacent focus areas

Men's Sexual Health

Menopause & Women's Health

Thyroid

Cardiometabolic Risk